Mediscience ploughs ahead with prostate cancer test
This article was originally published in Clinica
Executive Summary
Mediscience Technologyis stepping up its efforts to make a noninvasive diagnostic test for prostate cancer with the formation of a subsidiary company to develop the test. The new company, called ProScreen, aims to have its Uni-Tech System on the US market within 24-36 months.